Back to Journals » Breast Cancer: Targets and Therapy » Volume 15

Traditional Chinese Medicine for Breast Cancer: A Review

Authors Feng RQ, Li DH , Liu XK, Zhao XH , Wen QE, Yang Y

Received 7 July 2023

Accepted for publication 5 October 2023

Published 27 October 2023 Volume 2023:15 Pages 747—759

DOI https://doi.org/10.2147/BCTT.S429530

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Pranela Rameshwar



Rui-Qi Feng,1 De-Hui Li,2 Xu-Kuo Liu,1 Xiao-Hui Zhao,1 Qian-Er Wen,1 Ying Yang1

1Graduate School of Hebei University of Chinese Medicine, Shijiazhuang, Hebei Province, People’s Republic of China; 2Oncology Department II, the First Affiliated Hospital of Hebei University of Chinese Medicine (Hebei Province Hospital of Chinese Medicine), Shijiazhuang, Hebei Province, People’s Republic of China

Correspondence: De-Hui Li, Email [email protected]

Abstract: A total of 18% of global breast cancer (BC) deaths are attributed to BC in China, making it one of the five most common cancers there. There has been a steady rise in BC morbidity and mortality in women in the last few years and it is now a leading cancer among Chinese women. Conventional treatments for BC are currently effective but have several limitations and disadvantages, and Traditional Chinese medicine (TCM) plays a vital role in the overall process of cancer prevention and therapy. It is known that TCM can treat a variety of conditions at a variety of sites and targets. In recent years, increasingly, research has been conducted on TCM’s ability to treat BC. TCM has shown positive results in the treatment of breast cancer and the adverse effects of radiotherapy and chemotherapy. This review describes the progress of clinical observation and mechanism research of TCM in the treatment of breast cancer in recent years. It provides some ideas and theoretical basis for the treatment of BC with TCM.

Keywords: formulas, acupuncture, mechanism of action, therapy

Introduction

Among all cancer types, breast cancer (BC) is the fifth leading cause of cancer worldwide, with the highest incidence among Chinese women.1 Surgery and chemotherapy, targeted therapy, and endocrine therapy are currently used as an anti-cancer therapy for Western medicine.2 However, there are many disadvantages and limitations: postoperative complications, recurrences and metastases, and many different kinds of side effects.3 Despite this, TCM plays an important role in cancer treatment due to its multiple sites and targets.4,5

The main clinical manifestations of BC are breast nodules, nipple and areola abnormalities, nipple discharge, and breast skin changes including skin infiltration, ulcers, satellite nodules, and eczema-like changes.6 The cause of BC is still unclear, but the development of BC is closely linked to a number of conditions, like race, ethnicity, family history of cancer, genetic variants, excessive estrogen, high intake of high-fat, high-protein diet, chronic alcohol consumption and younger age of menarche and older age of first full-term pregnancy, which is related to female reproductive factors.7,8

TCM has a rich theoretical foundation and clinical application in the treatment of breast cancer and has been widely used in clinical practice. Breast cancer is among the 95 illnesses that TCM considers effective for treatment and recommends. These conditions are acknowledged by the State Administration of Chinese Medicines.9 Due to TCM’s consideration of individual differences and the relationship between a person and his or her environment, it has some unique advantages when it comes to treating tumors.4 The advantages of Chinese medicine in the treatment of breast cancer also lie in its wide applicability, which is applicable to all types of breast cancer and all clinical stages, with no obvious toxic side effects.10 The clinical observation and experimental studies of a large number of drug targets and mechanisms of drugs have shown that some classic Chinese medicine prescriptions and chemical compounds isolated from TCM are effective in the management and prophylactic of BC. Acupuncture, in conjunction with TCM, constitutes a fundamental element of traditional Chinese medicine, and there is growing evidence that acupuncture can be a safe and effective treatment for BC, as well as for associated concomitant symptoms such as chronic pain, hot flushes, fatigue, neuropathy, nausea and vomiting, dry mouth and difficulty swallowing.10,11 This reviews the progress of research in recent years on the treatment of BC and its adverse effects.

Pattern Identification of BC in TCM

The diagnosis of BC is based on a mixture of pathology identification and differentiation in TCM. The main characteristics of disease identification can be divided into lumps, nipple discharge, skin changes, and nipple areola changes. In traditional Chinese medicine, BC disease is closely associated with the liver, spleen, stomach and kidneys. TCM believes that BC is mainly caused by the internal invasion of external pathogens and the deficiency of vital qi, resulting in an imbalance of viscera, meridians, qi, blood, body fluid, and yin and yang, leading to abnormal physiological functions of the breast.12

The etiology can be summarized as follows:13 six exogenous factors which cause diseases and pathogenic toxin; deficiency of healthy qi and deficiency of both qi and blood; internal injury by the seven emotions; improper diet; toxic heat accumulation; congenital endowment. Patients are generally classified into the following types based on their pathological changes in yin and yang, qi and blood, viscera, meridians, and other aspects:14–16 liver qi stagnation, toxic heat accumulation, deficiency of qi and blood, imbalance of Chong and Ren (Table 1).17,18

Table 1 Pattern Identification of BC in TCM

TCM in the Therapy of BC

TCM Formulas in the Therapy of BC

BC has different treatment purposes according to different disease stages. The treatment purpose of stage 0, stage I, stage II and stage III is to cure as much as possible, and stage IV is palliative treatment.8 In clinical practice, many classic Chinese herbal decoctions or improved decoctions have obvious effects on the treatment of BC. Xiang Bei Yang Rong Tang (XBYRT),19 Ruyiping,20 Buqi YangXue decoction,21 Shu Gan Jian Pi Granules,22 Wuling San,23 Huangqi Sijunzi decoction,24 Xiaoai Jiedu Recipe,25 Shenqi FuZheng injection,26 Sini San,27 Xiaochaihutang,28 Kangai Injection,29 Taohong Siwu Decoction,30 Yanghe Tang,31 and so on, are widely used in clinical practice.

Relieve Cancer Fatigue

A very prevalent symptom of BC is cancer-related fatigue, for which many TCM decoctions have been proved to be effective. XBYRT can cure cancer-related fatigue caused by qi and blood deficiency.19 Shu Gan Jian Pi Granules can treat BC-related fatigue caused by stagnation of liver qi and weakness of spleen qi.22 Huangqi Sijunzi decoction can treat cancer fatigue in the form of spleen and stomach qi deficiency after chemotherapy for BC.24

Suppressing the Progression of BC

Xihuang pill as a Chinese patent medicine, it has unique efficacy for treating BC, can inhibit the atypical hyperplasia of BC, and shows a marked cytotoxic activity on MDA-MB-231 and MCF-7 human BC cells. Li believes that Xihuang pill can be used alone as a treatment drug for BC.32,33 Li and his research partners noted that Ruyiping may have an inhibitory effect on BC growth and metastasis by regulating cell cycle termination.20 Xiaoai Jiedu decoction can effectively suppress BC cell proliferation and trigger cancer cell apoptosis.25 Sini San can help prevent BC from stemness and spreading.27 Yanghe Huayan decoction significantly restrained BC cell invasion and angiogenesis.34 Xiao tan Jieyu Decoction discovered that this recipe can block the development of tumors and decrease the occurrence of BC and can also inhibit PI3K/AKT signal transduction pathway to effectively reduce the development of BC lesions.35

Treatment Complications

As a frequent consequence of mastectomy, upper extremity lymphoedema may lead to bodily discomfort, emotional distress, disfigurement and loss of function. Wuling San can effectively treat upper limb lymphedema after mastectomy.23 Cancer-related fatigue (CRF) has been identified as among the most distressing symptoms of breast cancer patients. ShuGan JianPi granules and Bu Zhong Yiqi Decoction may contribute to the identification of an effective intervention for CRF.36 Some studies have indicated that breast cancer patients are more prone to anxiety and depression.37 The use of Shuyu pill in the chemotherapy of advanced breast cancer can alleviate anxiety and depression, decrease the occurrence of side effects, the improvement of related symptoms and enhance the quality of life of patients.38 Wenshen Zhuanggu Recipe found that it can alleviate the pain of bone metastasis of BC and mitigates microenvironment of tumor cells, control the tumor epithelial–mesenchymal transition (EMT) process, reduce the growth and spread of tumor cells, and also reduce leukopenia, nausea, vomiting, gastrointestinal reaction, alopecia, and bone marrow suppression.30

Adjuvant Therapy

TCM decoctions are remarkably useful in the therapy of BC and its complications and can be used as an effective support to radiotherapy and chemotherapy to enhance their curative effects and reduce side effects. Buqi Yangxue decoction can improve the immune function, nutritional status, and TCM symptoms of BC patients after radiotherapy and chemotherapy.21,39 Shenqi FuZheng injection can improve the therapeutic results of chemotherapy, increase target response rate, enhance immune response and reduce side effects.26,40 Xiaochaihutang can influence the expression of neurotransmitter-related receptor genes and subsequently affect neuronal invasion in the BC tumor microenvironment to reach the goal of the therapy of BC.28 Huaier is a TCM, because its anti-cancer properties have attracted the attention of many researchers, and research has proved that it can inhibit the development of low toxic BC, enhance the response of immunity and increase the susceptibility to radiation therapy and chemotherapy, and can significantly inhibit proliferation and induce programmed cell death.41 It can also reduce levels of tumor markers.42 Yanghe Tang can enhance the efficacy of chemotherapy and can inhibit inflammation and improve the body’s microenvironment and immunity.43,44

The Chemical Compounds Isolated from Chinese Herbs for BC

The chemical components isolated from Chinese herbs also have therapeutic effects on BC, as evidenced by increasing amounts of research. Andrographolide (AD) is a chemical component isolated from Andrographis paniculata, which has a huge anti-tumor effect in a variety of tumors. AD can inhibit the proliferation of BC cells by inhibiting ESR1 transcription via the ROS-FOXM1 axis and may suppress BC cell growth by down-regulation of ER-A expression.45 Salvia miltiorrhiza is commonly used in liver cancer and cardiovascular diseases. The effective components extracted from Salvia miltiorrhiza I, II, cryptotanshinone, and dihydrotanshinone. Tanshinone can inhibit tumor cell proliferation and tumor growth, and prevent tumor angiogenesis through induction of apoptosis and cell cycle arrest in cancer cells, inhibition of metastatic phenotype, and enhancement of chemical sensitivity and radiosensitivity.46 Cimicifuga dahurica Maxim as TCM has a long history and the history in the treatment of BC can be traced back to the “Sheng-Ge decoction”. In recent years, the extract of Cimicifuga can inhibit the proliferation of BC cells and promote the apoptosis of BC cells.47 Evodiamine, a major bioactive component of Evodia rutaecarpa, can inhibit tumorigenesis, migration and vasculogenesis. Evodiamine (EVO) also induces apoptosis in Doxorubicin (DOX)-sensitive and DOX-resisting cells. It can enhance DOX apoptosis through inhibition of IAPs and the Ras/MEK/ERK cascade. It shows that Evodiamine can play a role in the treatment of BC whether used alone or in combination with chemotherapy drugs.48 G. lucidum spore oil (GLSO) is a TCM Ganoderma lucidum extract. GLSO can induce cell apoptosis through mitochondrial apoptosis, thereby inhibits MDA-MB-231 cell and tumor growth. Therefore, GLSO can be used as a new nutraceutical or drug for the prevention and treatment of breakthrough cancer.49 Icaritin (ICT) is a prenylated flavonoid derivative of the TCM Epimedii Herba. It has anti-cancer properties in several types of cancer. ICT derivative IC2 and demonstrate that IC2 is able to induce apoptosis in mitochondrial cells by blocking the function of stearoyl-CoA desaturase‑1 (SCD1). IC2 reduces the expression of the anti-apoptotic factor Bcl-2 by disrupting the mitochondrial membrane potential and promotes apoptosis along with the production of ROS. The result of the study is that IC2 might be a drug candidate to combat BC.50 Matrine (MAT) is an alkaloid that is extracted from the Sophora Flavescens, a TCM, which can be used to treat aggressive cancers. MAT has been shown to inhibit the growth of MDA-MB-231 cells and is an effective apoptosis inducer. It may be a new inhibitor of BC.51 Osthole, as a major extract from Cnidium monnieri (L.), blocks the growth, proliferation, and intrusion of BC cells, and induces apoptosis of BC cells. It also regulates osteoprotegerin/receptor activator of NF-κB ligand (OPG/RANKL) signaling when osteoblasts interact with cancer cells. Inhibition of bone spread in BC through inhibition of the Transforming growth factor beta/Smads (TGF-β/Smads) signaling pathway during bone spread in MDA-MB-231 cells.52 Red ginseng polysaccharide (RGP), one of the red ginseng’s active components, has good anti-tumor activity. RGP may be used as a preventive medicine against BC by targeting glutathione peroxidase 4 (GPX4) to eliminate the protection of cancer cells from ferroptosis.53 Shikonin, a naphthoquinone derived from the Lithospermum erythrorhizon, has a wide range of uses. By reducing T tumor-derived exosomes, shikonin can suppress the proliferation of human BC cells, and can also inhibit tumor proliferation by regulating the release of exosomes to change the tumor microenvironment.54 Shikonin (SKO) has significant cytotoxicity to MDA-MB-231 cells, which could become a candidate to treat triple-negative BC.55

Acupuncture for BC

There are many adverse effects associated with BC treatment, whether it is surgery, radiotherapy or chemotherapy. Acupuncture, as well as traditional herbal decoction, has an essential function in treating side effects. Acupuncture is a holistic therapy, which is part of TCM. The principle of treatment of TCM is coordinating yin and yang. And acupuncture can operate by stimulating the pathways or meridians that carry the body’s vital energy, which has a regulating and balancing effect on various organs and the body as a whole.56

A common symptom for late-stage cancer patients is pain. Safe and effective pain relief can effectively improve quality of life for late-stage patients. Acupuncture can activate the pain modulation system in the body, promote the production and release of endogenous opioids in the body, and thus alleviate pain.57 Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common side effects in cancer patients during and after chemotherapy. Most CIPN treatments currently used are based on Western medicines, but these can cause side effects such as fatigue, dizziness and insomnia.58 Acupuncture combined with painkillers can safely and effectively relieve the pain caused by cancer.59 Insomnia is a prevalent side effect that can occur during and after chemotherapy. Acupuncture may alleviate the over-activated sympathetic nerves of the patients.60 And that’s why acupuncture and moxibustion can effectively alleviate insomnia caused by cancer.61,62 BC complicated with upper limb edema often uses western medicine in clinical practice. Studies have demonstrated that acupuncture in affected limbs can unblock occluded lymphatic vessels, enhance the phagocytosis of leukocytes and reduce the inflammatory response. At the same time, acupuncture could release lymphatic fluid and relieve the load of the lymphatic system in the affected area, which is conducive to local tissue oedema and inflammation absorption.63 Taking Chinese herbal recipe in conjunction with acupuncture could better enhance the symptoms of affected limbs and relieve pain, improve clinical efficacy, and promote the recovery of limb function.64,65 Patients often have nausea and vomiting after chemotherapy. So, a lot of antiemetic drugs are clinically used to prevent the chemotherapy-induced nausea and vomiting (CINV), but these antiemetic drugs may cause a variety of adverse effects. Acupuncture as an additional treatment not only mitigates the adverse effects but is also safer and more tolerable. Wang concluded that acupuncture can effectively improve nausea and vomiting after chemotherapy, and its effect is no less than taking western medicine.65 The mechanism of acupuncture could be to stimulate and induce alterations in the levels of hormones and neurotransmitters related to regulating appetite controlling, such as the monoamine neurotransmitters 5-HT, gastrointestinal hormones, and NTS cells.66 Summarize the mechanism of action of acupuncture above (Table 2).

Table 2 Mechanism of Action of Acupuncture

Pharmacological Mechanism of Chinese Medicine Against BC

According to clinical observations and experimental research results, the pharmacological effects of Chinese herbal medicine in the prevention and treatment of BC can be divided into several categories: affecting cell proliferation and apoptosis, regulating autophagy, inhibiting EMT, and improving the microenvironment. The relevant mechanisms for affecting cell proliferation and apoptosis include affecting relevant signaling pathways, proto-oncogenes and tumor suppressor genes, or acting directly on BC cells (Figure 1) (Table 3).

Figure 1 Pharmacological mechanisms of TCM for treating BC. By Figdraw (ID ROTRUbb55b).

Table 3 Mechanism of Action of TCM

Cell Proliferation and Apoptosis

Relevant Signal Pathway

One critical mechanism by which BC cells proliferate and undergo apoptosis is by interfering with the signaling pathways involved.

AC Roots is the root of Actinidia chinensis Planch. Its extract suppressed BC cell growth, proliferation, invasion and increased apoptosis of BC cells via the AKT/GSK-3b pathway.71 Ai du Qing formula can inhibit TAM/CXCL1/Treg pathway and inhibit immune escape and lung metastasis of BC.72 Mammalian target of rapamycin (mTOR) was identified as the key molecule of multiple signal transduction pathways, and its upstream PI3K/AKT constitutes the PI3K/Akt/mTOR signal pathway. This pathway is highly expressed in BC, regulating cell proliferation, apoptosis, transcription, translation, metabolism, and so on. It is a crucial cell biological procedure in the developing organism and progression of BC. Xihuang Pill can inhibit BC cell development, ingression and migration and suppress tumor angiogenesis through this pathway found that Xihuang Pill can down-regulate NF- κ B protein expression, thus blocking BC from developing and progressing.74,75 Alkali ethanol as the extract of A. raddeana. The extract was called total secondary saponin (TSS) and found that TSS can block the triggering of the PI3K/AKT/mTOR signal pathway, thereby promoting the expression of the mitochondria cell death pathway, and can markedly attenuate the growth of MCF-7 cells.67 As a bioactive ingredient derived from the roots of Scutellaria baicalensis, baicalein can inhibit the PI3K/AKT pathway in and ex vivo to cause apoptosis and autophagy in BC cells.68 Astragalus membranaceus extract inhibits the growth of BC cells through the PI3K/AKT/mTOR signaling pathway.101 Ephrin-B2 contributes to cancer cell survival, invasion and migration. Berberine significantly inhibited tumor cell growth and migration through the Ephrin-B2 signaling pathway.73 As the major constituent from the roots of Euphorbia Fischeriana Steud, ethyl gallate can inhibit BC metastasis through a signal pathway.76 Eight flavonoids and three flavonoids are extracted from Turcz. ex DC., which can induce apoptosis and autophagy of human BC cells, found that flavonoids can also suppress cell proliferation and trigger apoptosis and autophagy via the PI3K/AKT/mTOR/p70S6K/ULK pathway.69 Guizhi Fuling Decoction has the function of anti-proliferation, promoting apoptosis and anti-angiogenic, which mainly inhibits BC cells achieved by modulating the PI3K and MAPK signaling pathways.70 Jin’gan capsules (JGCs) suppress BC cell proliferation and induce cell cycle arrest and apoptosis partly by inhibiting the JAK2/STAT3 signaling pathway.77 The effective ingredients of Xiao ai Jie du decoction: quercetin and ursolic acid, through the combination of both, the mitochondrial membrane potential is notably reduced and the activity of PI3K Akt signaling pathway is inhibited, which induces cancer cell death.25 Taohong Siwu Decoction (TSD) can significantly inhibit KRAS signaling in cancer and activation of the apoptosis pathway, p53 pathway, and hypoxia pathways inhibits the growth and spread of cancer cells, induction of G1 arrest and apoptosis of MDA-MB-231 cells can regulate the expression of MYC, BIRC5, EGF and PIK3R1.79 Yang he decoction, which inhibits 4T1 breast tumor growth, is mainly through negative regulation of JAK/STAT3 pathway.78

Proto-Oncogene and Tumor Suppressor Gene

Polygonatum odoratum (P. odoratum) is widely used in TCM, and P. odoratum extract may have an inhibitory effect on the growth of MDA-MB-231 human BC cells and induce their apoptosis by upregulating Bax expression and inhibiting Bcl-2 expression.80 Ruanjian Sanjie decoction shows potent cytotoxicity in vitro against BC cells by suppressing the antiapoptotic proteins B-cell lymphoma 2 and survival, which leads to the caspase 3/7 and caspase 9 activation and the apoptotic process.81 A new combination of Chinese herbs known as SANT. SANT promotes autophagic flux and inhibits tumor angiogenesis by regulating the production of related genes and proteins, increasing the production of ATG16L1, ATG9B and ATG4D genetic factors and decreasing the production of TMEM74 (new autophagy-related genes) and TNF (tumor necrosis factor) genes.82 Rupifang extract in rat models of breast hyperplasia found that Rupifang can increase the expression of tumor inhibitor P16 by inhibiting the expression of the pro-oncogene HER2, which can efficiently prevent the onset and progression of BC.83

Direct Inhibition of Human BC Cells

Arctigenin is a bioactive lignan which has been extracted from the Arctium lappa L. Arctigenin downregulates MMP-2, MMP-9 and heparanase to inhibit infiltration and metastasis of MDA-MB-231 cancer cells.84 Berberine and Evodiamine acted synergistically to increase BAX protein levels, upregulate the expression on caspase-9 and caspase-7, and subsequently induce cell cycle exit and promote apoptosis in the MCF-7 human BC cellular line.85 Cantharidin, the active compound of the beetle Mylabris, which is widely used in traditional Chinese medicine, is a powerful and specific blocker of the protein phosphatase 2A (PP2A), playing a key role in cell cycle development, division and cell differentiation. Lin and colleagues discovered that DT, a pure substance found in BC, suppressed the development of MCF-7 and MDA-MB-231 cells in vivo and in vitro, and inhibited expression of apoptosis and ferrogenesis in these BC cells.89 Luteolin, the main bioactive compound of T. officinale, effectively suppressed MDA-MB-231 and MCF-7 cell multiplication and migration.90 G. lucidum spore oil (GLSO) is a lipophilic compound which is derived from the sporophyll of G. lucidum spores. GLSO may upregulate caspase-3 and caspase-9, exhibit mitochondrial apoptosis-induced inhibited growth in MDA-MB-231 cells, and induce tumor cell apoptosis in vivo.49 Oxymatrine, a major active and toxic alkaloidal ingredient from the roots of Sophora japonica, may have an important role in inhibiting oncogenic BC cells by promoting MCF-7 apoptosis through modulating the expression levels of Bax and bcl-2.86 There are two phases in the cell cycle. Intermediate phase includes G1, S and G2 stages. Bakuchiol, an effective substance in the TCM Fructus Psoraleae, can inhibit BC through the induction of S phase apoptosis and inhibition.87 The water extract of Da Huang has potential anti-cancer properties by inhibiting proliferation and apoptotic effects in MCF-7 and A549 cell line analysis.88

Regulation of Autophagy

As a main protostane triterpene from Alismatis Rhizoma, Alisol A significantly inhibited cell viability. Induction of apoptosis in MDA-MB-231 cells exits from the G1 phase of the cell cycle, the activity of autophagy and the generation of inter-cellular reactive oxygen species (ROS) in MDA-MB-231 cells. Treatment with Alisol A induces autophagy-dependent apoptosis in mammary normal cancer cells through the induction of reactive oxygen species and DNA injury.91 Ai Du Qing formulation can pass through the GRP78/β-catenin ABCG2 regulating axis of autophagy to prevent the development of BC.92

Suppress EMT

EMT participates in tumor infiltration and metastases by generating more motile and invasive cells. The control of EMT can be a potential target for preventive care and management of metastatic tumor.102 Honokiol (HNK) reduces the expression of Snail and Slug genes at the level of mRNA translation, inhibiting EMT in BC cells.93 Bone marrow induced mesenchymal stem cells (BMSCs) aggravate the formation and progress of tumors. Inside the tumor microenvironment, BMSC can directly or indirectly influence the behavior of neighboring tumor cells through paracrine secretion and increase tumor cell capacity through motility, tumorigenicity, and metastasis. The Wenshen Zhuanggu formula inhibits EMT and bone metastasis in BMSC-induced BC.94

Improving the Microenvironment

Tumor microenvironment offers a friendly environment for cancer cell development. Tumor microenvironment components are affected by tumor cell gene composition and patients may also be at increased risk of invasive tumors and faster disease progression due to other non-oncological factors, leading to early onset, to adversely affect the survival of patients.103 Cancer cells and other cells in the cancer microenvironment are involved in metastatic spread (for instance stromal cells, immune cells). These cells secrete a variety of regulatory cytokines and/or growth agents, which in reverse have an impact on the progression of BC through a number of different mechanisms. Inflammation, by establishing a favorable immune microenvironment, may affect the development, metastases and prognosis of BC. Xihuang Pill significantly suppresses BC development by targeting multiple carbohydrate and inflammatory microenvironment signaling pathways.95 Th1 and Th2 are mainly involved in a cellular immune response. The Th1/Th2 ratio of tumor patients changes, which leads to inhibition of anti-tumor immune response, so that cancerous cells can survive and improve the appearance and progress of malignant tumors. Li and other researchers consider that the immune microenvironment has an essential part in the development and growth of BC,104 closely associated with the PI3K/AKT and PD-1/PD-L1 signal transduction pathway and inhibits the progression of lymphoma.96 They found that Xihuang pill can serially enhance IFN-γ and IL-2, inhibit IL-4 and IL-10, and modulate Th1/Th2 cell balance, improving the immune microenvironment.98,99 Saikosaponin A (SSA) is separated from the dried radical of Radix Bupleuri. SSA suppresses BC by increasing penetration of CD8+ T cells and CD4+ T cells into the microenvironment of the tumor and promoting a Th1/Th2 bias towards a Th1 immunity.97 Sanhuang Decoction improves tumor microenvironment by regulating pressure-related factors, inflammation, hemorheology, blood lipids, immunity, and angiogenesis factors; all of these functions can help tumors grow or become resistant to drugs. Sanhuang Decoction can effectively relieve chronic stress state and control the tumor microenvironment by improving chronic oxidative stress within the body.100 As immunosuppressors, MDSCs enhance T-cell apoptosis and inhibit natural killer cell antioxidant activity. Yanghe Tang is able to reduce the development of 4T1 lymphoma cells through a reduction in the number of MDSCs in the tumor microenvironment.78

Conclusions and Perspectives

There is an urgent need for more effective treatments for BC, which is one of the most frequent cancers in women. For the treatment in BC, TCM shows distinct benefits. Traditional decoctions, traditional herbal medicines and traditional herbal extracts are all important for treating BC. This finding could have important implications for treating BC. At present, the use of TCM-supported radiotherapy and chemotherapy for the treatment of BC is more common in clinical practice, to enhance effectiveness and decrease side effects and drug resistance. Many studies have demonstrated that TCM works well against BC. It has a positive impact on the prevention and treatment of anti-tumor therapy-related side effects, and plays an important role in promoting the recovery of patients’ physical fitness after anti-tumor therapy, reducing recurrence and metastasis, and improving the quality of survival.

However, the current clinical trials supporting the theoretical basis are insufficient, and the specific mechanisms of action and adverse effects of some TCM are still unclear. At the same time, due to the characteristics of Chinese medicine treatment, there is a lack of standardized symptomatology and uniform evaluation of the efficacy of TCM. Further extensive and in-depth research and development are necessary for some traditional medicines, as well as the rational standardization of these medicines in order to facilitate their clinical promotion and application.

In the future, we can further clarify the mechanism of action of TCM in the treatment of BC, on the basis of which we can improve the efficacy of TCM, standardise the diagnosis and treatment of BC in TCM, and provide more precise clinical guidance.

Acknowledgments

This research was supported by the National Natural Science Foundation of China (Grant no. 81603412); Health Commission of Hebei Province (Grant no. 20220962); Scientific Research Project of Hebei Administration of Traditional Chinese Medicine (Grant no. 2023045; Grant no. 2024023); General Projects for Improving Scientific Research Capacity of Hebei College of Traditional Chinese Medicine (Grant no. KTY2019009); Hebei Province “Three Three Three Talent Project” funded project (Grant no. A202002008); and Hebei Graduate Innovation Funding Project (Grant nos. XCXZZSS2023017 and XCXZZSS2023027). We also thank Figdraw platform for visualization.

Disclosure

The authors declare that they have no conflicts of interest for this work.

References

1. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics. Chin Med J. 2021;134(7):783–791. doi:10.1097/CM9.0000000000001474

2. Waks AG, Winer EP. Breast Cancer Treatment: a Review. JAMA. 2019;321(3):288–300. doi:10.1001/jama.2018.19323

3. Spronk I, Schellevis FG, Burgers JS, de Bock GH, Korevaar JC. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: a systematic review. Breast. 2018;39:70–79. doi:10.1016/j.breast.2018.03.011

4. Zhou J, Zhou T, Jiang M, et al. Research progress on synergistic anti-tumor mechanisms of compounds in traditional Chinese medicine. J Tradit Chin Med. 2014;34(1):100–105. doi:10.1016/s0254-6272(14)60062-5

5. Qi F, Zhao L, Zhou A, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015;9(1):16–34. doi:10.5582/bst.2015.01019

6. Owczarczyk-Saczonek AB, Sigorski D, Różanowski P. Cutaneous manifestations of breast cancer. Przegl Dermatol. 2017;5(5):561–569. doi:10.5114/dr.2017.71221

7. Coughlin SS. Epidemiology of Breast Cancer in Women. Adv Exp Med Biol. 2019;1152:9–29. doi:10.1007/978-3-030-20301-6_2

8. Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017;50(1):33. doi:10.1186/s40659-017-0140-9

9. I C, M T, D T. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 2002;29(6). doi:10.1053/sonc.2002.50005

10. Zia FZ, Olaku O, Bao T. The National Cancer Institute’s Conference on Acupuncture for Symptom Management in Oncology: state of the Science, Evidence, and Research Gaps. J Natl Cancer Inst Monogr. 2017;2017(52):lgx005. doi:10.1093/jncimonographs/lgx005

11. Greenlee H, DuPont-Reyes M. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194–232. doi:10.3322/caac.21397

12. Zhang Y, Tian X. Exploring traditional Chinese medicine-based diagnosis and treatment of breast cancer based on molecular typing. J Beijing Univ Traditional Chin Med. 2023;46(7):1025–1031.

13. State Administration of Traditional Chinese Medicine. The Standard for TCM Diseases and Syndromes therapeutic results. China Traditional Chine Med Press. 2012.

14. Jiang J, Liu H, Li S. Research Progress on Traditional Chinese Medicine classification of breast cancer. J New Chine Med. 2014;46(8):197–199. doi:10.13457/j.cnki.jncm.2014.08.088

15. Zhang J, Wu X, Li T. Differentiation of Symptom Complex of Breast Cancer by Integrated Medicine. Chine J Surgery Integrated Traditional Western Med. 2001;1:14–16. doi:10.3969/j.issn.1007-6948.2001.01.007

16. Guo Q. Chinese Medicine Syndrome Differentiation for Early Breast Cancer: a Multicenter Prospective Clinical Study. Front Oncol. 2022;12:914805. doi:10.3389/fonc.2022.914805

17. Zhou L, Gao H, Zhang HW, et al. Clinical study on the relationship between TCM differential typing and molecular typing of breast cancer. Jiangsu J Traditional Chine Med. 2015;47(01):32–34.

18. Chen J. Professor Sun Guizhi combined with the experience of treating breast cancer and clinical research. China Academy Chine Med Sci. 2012.

19. Yap NY, Loo WS, Zheng HF. A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trial. Trials. 2020;21(1):909. doi:10.1186/s13063-020-04810-4

20. Li Z, Sun X, Liu X, Sun Z, Li J. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer. Cancer Biother Radiopharm. 2019;34(5):297–305. doi:10.1089/cbr.2018.2703

21. Liu M. Effects of Chinese Herbal Formula on Immune Function and Nutritional Status of Breast Cancer Patients. Comput Math Methods Med. 2022;2022:5900024. doi:10.1155/2022/5900024

22. Li C, Yang G, Yu M, et al. Effects of traditional Chinese medicine Shu Gan Jian Pi granules on patients with breast cancer and cancer-related fatigue: study protocol for a randomized controlled trial. Trials. 2015;16(1):192. doi:10.1186/s13063-015-0723-0

23. Zhu H, Peng Z, Dai M. Efficacy and safety of Wuling San for treatment of breast-cancer-related upper extremity lymphoedema: study protocol for a pilot trial. BMJ Open. 2016;6(12):e012515. doi:10.1136/bmjopen-2016-012515

24. Cui Y, Mi J, Feng Y. Huangqi Sijunzi decoction for treating cancer-related fatigue in breast cancer patients: a randomized trial and network pharmacology study. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(5):649–657. doi:10.12122/j.issn.1673-4254.2022.05.04

25. Li Y, Li R, Zeng Z. Prediction of the mechanisms of Xiaoai Jiedu Recipe in the treatment of breast cancer: a comprehensive approach study with experimental validation. J Ethnopharmacol. 2020;252:112603. doi:10.1016/j.jep.2020.112603

26. Zhang H, Chen T, Shan L. ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis. Pharm Biol. 2019;57(1):612–624. doi:10.1080/13880209.2019.1660383

27. Zheng Y, Zhang J, Huang W. Sini San Inhibits Chronic Psychological Stress-Induced Breast Cancer Stemness by Suppressing Cortisol-Mediated GRP78 Activation. Front Pharmacol. 2021;12:714163. doi:10.3389/fphar.2021.714163

28. Zheng L, Jiang H, Li R. The Pharmacological Mechanisms of Xiaochaihutang in Treating Breast Cancer Based on Network Pharmacology. Contrast Media Mol Imaging. 2022;2022:3900636. doi:10.1155/2022/3900636

29. Xue J-X, Zhu Z-Y, Bian W-H, Yao C. The Traditional Chinese Medicine Kangai Injection as an Adjuvant Method in Combination with Chemotherapy for the Treatment of Breast Cancer in Chinese Patients: a Meta-Analysis. Evid Based Complement Alternat Med. 2018;2018:6305645. doi:10.1155/2018/6305645

30. Jiang H, Li M, Du K. Traditional Chinese Medicine for adjuvant treatment of breast cancer: taohong Siwu Decoction. Chin Med. 2021;16(1):129. doi:10.1186/s13020-021-00539-7

31. Zhang X, Hu MH, Li S. Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients. Medicine. 2022;101(10):e29031. doi:10.1097/MD.0000000000029031

32. Li DH, Fan HF, Sun CX. Research progress on the application of Xihuang Pill in breast cancer. Lishizhen Med Materia Med Res. 2016;27(09):2247–2248.

33. Li DH, Su YF, Fan HF, et al. Effect of Xihuang Pill on Hemorheological Properties in DMBA Combined Estrogen and Progesterone Induced Breast Precancerous Lesions Rats. Basic Clin Pharmacol Toxicol. 2020.

34. Liu XF, Li JW. Yanghe Huayan decoction inhibits the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling. Biosci Rep. 2019;39(2):BSR20181260. doi:10.1042/BSR20181260

35. Zhao J, Pang T, Jiao JP, et al. Xiaotan Jieyu Prescription Alleviates Breast Precancerous Lesions through PI3K/Akt Signaling Pathway. Evid Based Complement Alternat Med. 2020;2020:4129461. doi:10.1155/2020/4129461

36. Jeong JS, Ha Ryu B, Sung Kim J, Woo Park J, Cheol Choi W, Woo Yoon S. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr Cancer Ther. 2010;9(4):331–338. doi:10.1177/1534735410383170

37. Park EM, Gelber S, Rosenberg SM. Anxiety and Depression in Young Women With Metastatic Breast Cancer: a Cross-Sectional Study. Psychosomatics. 2018;59(3):251–258. doi:10.1016/j.psym.2018.01.007

38. Zhu Y, Xing Y. Effects of Shuyu Pill on Anxiety and Depression of Patients with Advanced Breast Cancer Treated by Chemotherapy. Anti-Tumor Pharmacy. 2018;59(3):251–258. doi:10.1016/j.psym.2018.01.007

39. Li S. Clinical Observation on Guipi Decoction in the Treatment of Syndrome of Deficiency of Blood and Blood after Breast Cancer Operation. Chine Med Modern Educ China. 2022;20(24):85–87. doi:10.3969/j.issn.1672-2779.2022.24.030

40. S L. Shenqi Fuzheng Injection in the Treatment of Breast Cancer: a Meta-analysis of Randomized Controlled Trials. Integr Cancer Ther. 2019;18. doi:10.1177/1534735418816824

41. Li C, Wang X, Chen T, Wang W, Yang Q. Trametes robiniophila Murr in the treatment of breast cancer. Biomed Pharmacother. 2020;128:110254. doi:10.1016/j.biopha.2020.110254

42. Chen Y, Liu J. Clinical study on Huaier Granules combined with AP scheme in treatment of breast cancer. sDrugs & Clinic. 2020;35(1):52–55. doi:10.7501/j.issn.1674-5515.2020.01.011

43. Li DH, Su YF, Fan HF, Guo N, Sun CX. Acupuncture Combined with Three-Step Analgesic Drug Therapy for Treatment of Cancer Pain: a Systematic Review and Meta-Analysis of Randomised Clinical Trials. Evid Based Complement Alternat Med. 2021;2021(2021):5558590. doi:10.1155/2021/5558590

44. Y Y, X C. Jiawei Yanghe Decoction suppresses breast cancer by regulating immune responses via JAK2/STAT3 signaling pathway. J Ethnopharmacol. 2023;316. doi:10.1016/j.jep.2023.116358

45. Xu T, Jiang Y, Yuan S, et al. Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis. Front Oncol. 2022;12:899402. doi:10.3389/fonc.2022.899402

46. Jin Z, Chenghao Y, Cheng P. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer. Front Pharmacol. 2022;12:824531. doi:10.3389/fphar.2021.824531

47. Jia H, Wang X, Liu W, et al. Cimicifuga dahurica extract inhibits the proliferation, migration and invasion of breast cancer cells MDA-MB-231 and MCF-7 in vitro and in vivo. J Ethnopharmacol. 2021;277:114057. doi:10.1016/j.jep.2021.114057

48. Wang S, Wang L, Shi Z, Zhong Z, Chen M, Wang Y. Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein. PLoS One. 2014;9(5):e97512. doi:10.1371/journal.pone.0097512

49. Jiao C, Chen W, Tan X, et al. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. J Ethnopharmacol. 2020;247:112256. doi:10.1016/j.jep.2019.112256

50. Yang C, Jin YY, Mei J, et al. Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis. Cancer Cell Int. 2022;22(1):202. doi:10.1186/s12935-022-02621-y

51. Ren L, Mo W, Wang L, Wang X. Matrine suppresses breast cancer metastasis by targeting ITGB1 and inhibiting epithelial-to-mesenchymal transition. Exp Cancer x. 2020;19(1):367–374. doi:10.3892/etm.2019.8207

52. Wu C, Sun Z, Guo B, et al. Osthole inhibits bone metastasis of breast cancer. Oncotarget. 2017;8(35):58480–58493. doi:10.18632/oncotarget.17024

53. Zhai FG, Liang QC, Wu YY, Liu JQ, Liu JW. Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis. Pharm Biol. 2022;60(1):909–914. doi:10.1080/13880209.2022.2066139

54. Wei Y, Li M, Cui S, et al. Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes. Molecules. 2016;21(6):777. doi:10.3390/molecules21060777

55. Wang A, Liu J, Yang Y, et al. Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells. Chin Med. 2021;16(1):16. doi:10.1186/s13020-021-00426-1

56. Li H, Schlaeger J, Jang MK. Acupuncture Improves Multiple Treatment-Related Symptoms in Breast Cancer Survivors: a Systematic Review and Meta-Analysis. J Altern Complement Med. 2021;27(12):1084–1097. doi:10.1089/acm.2021.0133

57. Ge L, Wang Q, He Y. Acupuncture for cancer pain: an evidence-based clinical practice guideline. Chin Med. 2022;17(1):8. doi:10.1186/s13020-021-00558-4

58. W L. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: a Randomized Controlled Pilot Trial. The Oncologist. 2020;25(4). doi:10.1634/theoncologist.2019-0489

59. Li DH, Su YF, Fan HF, Guo N, Sun CX. Acupuncture Combined with Three-Step Analgesic Drug Therapy for Treatment of Cancer Pain: a Systematic Review and Meta-Analysis of Randomised Clinical Trials. Evid Based Complement Alternat Med. 2021;2021:5558590. 26. doi:10.1155/2021/5558590

60. de Zambotti M, Covassin N, De Min Tona G, Sarlo M, Stegagno L. Sleep onset and cardiovascular activity in primary insomnia. J Sleep Res. 2011;20(2):318–325. doi:10.1111/j.1365-2869.2010.00871.x

61. Wang CC, Han EY, Jenkins M, et al. The safety and efficacy of using moxibustion and or acupuncture for cancer-related insomnia: a systematic review and meta-analysis of randomised controlled trials. Palliat Care Soc Pract. 2022;16:26323524211070569. doi:10.1177/26323524211070569

62. J Z. Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial. Breast Cancer Res. 2023;25(1). doi:10.1186/s13058-023-01645-0

63. Gao L, Wang X, An X. Clinical Study of Needling Collaterals and Needle-Warming Moxibustion Combined with Tuina along Meridian in the Treatment of Upper Limb Lymphedema. J Clin Acupuncture Moxibustion. 2020;36(7):30–34. doi:10.3969/j.issn.1005-0779.2020.07.009

64. Liu Y. Clinical Study on Jianpi Huoxue Jiedu Tang and Warming Acupuncture and Moxibustion Combined with Routine Therapy for the Upper Limb Edema after Breast Cancer Surgery. J New Chinese Med. 2019;51(12):235–238. doi:10.13457/j.cnki.jncm.2019.12.071

65. Wang L. Clinical Study on Nausea and Vomiting caused by postoperative Chemotherapy in Breast cancer with Space-time Acupuncture program of Ling Turtle Eight Methods. Yunnan Univ Chine Med. 2020. doi:10.27460/d.cnki.gyzyc.2020.000122

66. Baek JY. Electro-Acupuncture Alleviates Cisplatin-Induced Anorexia in Rats by Modulating Ghrelin and Monoamine Neurotransmitters. Biomolecules. 2019;9(10):624. doi:10.3390/biom9100624

67. Zhang D, Zhang Q, Zheng Y, Lu J. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation. J Ethnopharmacol. 2020;259:112984. doi:10.1016/j.jep.2020.112984

68. Yan W, Ma X, Zhao X, Zhang S. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro. Drug Des Devel Ther. 2018;12:3961–3972. doi:10.2147/DDDT.S181939

69. Zhang H, Hu J, Fu R, et al. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells. Sci Rep. 2018;8(1):11255. doi:10.1038/s41598-018-29308-7

70. Dai Y, Qiang W, Yu X, et al. Guizhi Fuling Decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS2 technology and systems pharmacology. Comput Struct Biotechnol J. 2020;18:1121–1136. doi:10.1016/j.csbj.2020.05.004

71. Gan C, Jin Z, Wei X, Jin M. Actinidia chinensis Planch. root extract inhibits the proliferation, migration and invasion of breast cancer cells via the AKT/GSK-3β signaling pathway. Folia Histochem Cytobiol. 2021;59(4):226–235. doi:10.5603/FHC.a2021.0023

72. Li J, Wang S, Wang N, et al. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration Cell Commun. Signal. 2021;19(1):89. doi:10.1186/s12964-021-00775-2

73. Ma W, Zhu M, Zhang D, et al. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2. Phytomedicine. 2017;25:45–51. doi:10.1016/j.phymed.2016.12.013

74. Li D, Su Y, Fan H, et al. XiHuang pill reversing precancerous lesions of breast cancer in rats and regulating the expression of NF-Kappa B protein. Chine J Gerontol. 2021;41(01):131–134.

75. Li D, Fan H, Sun C, et al. Effects of liquid extract of Xi Huang pills on motor and VEGF expression in precancerous cells of human breast cancer. Hunan J Traditional Chine Med. 2017;33(06):145–148. doi:10.16808/j.cnki.issn1003-7705.2017.06.068

76. Cui H, Yuan J, Du X, et al. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling. Oncol Rep. 2015;33(3):1284–1290. doi:10.3892/or.2014.3682

77. Qiu J, Zhang Z, Hu A, et al. Integrating UPLC-HR-MS/MS, Network Pharmacology, and Experimental Validation to Uncover the Mechanisms of Jin’gan Capsules against Breast Cancer. ACS Omega. 2022;7(32):28003–28015. doi:10.1021/acsomega.2c01921

78. Mao D, Feng L, Gong H. The Antitumor and Immunomodulatory Effect of Yanghe Decoction in Breast Cancer Is Related to the Modulation of the JAK/STAT Signaling Pathway. Evid Based Complement Alternat Med. 2018;2018:8460526. doi:10.1155/2018/8460526

79. Gui Y, Dai Y, Wang Y, Li S, Xiang L, Tang Y, Tan X, Pei T, Bao X and Wang D. (2022). Taohong Siwu Decoction exerts anticancer effects on breast cancer via regulating MYC, BIRC5, EGF and PIK3R1 revealed by HTS2 technology. Computational and Structural Biotechnology Journal, 20 3461–3472. 10.1016/j.csbj.2022.06.044

80. Tai Y, Sun YM, Zou X, et al. Effect of Polygonatum odoratum extract on human breast cancer MDA-MB-231 cell proliferation and apoptosis. Exp Ther Med. 2016;12(4):2681–2687. doi:10.3892/etm.2016.3630

81. Zhao X, Zhao J, Hu R, et al. Ruanjian Sanjie decoction exhibits antitumor activity by inducing cell apoptosis in breast cancer. Oncol Lett. 2017;13(5):3071–3079. doi:10.3892/ol.2017.5832

82. Li Q, Zhang G, Hao C, et al. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer. J Ethnopharmacol. 2021;266:113430. doi:10.1016/j.jep.2020.113430

83. Zhang G, Li D, Guo H, et al. Modulation of expression of p16 and her2 in rat breast tissues of mammary hyperplasia model by external use of rupifang extract. J Tradit Chin Med. 2012;32(4):651–656. doi:10.1016/s0254-6272(13)60087-4

84. Lou C, Zhu Z, Zhao Y, Zhu R, Zhao H. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells. Oncol Rep. 2017;37(1):179–184. doi:10.3892/or.2016.5269

85. Du J, Sun Y, Lu YY, et al. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis. Anticancer Res. 2017;37(11):6141–6151. doi:10.21873/anticanres.12063

86. Wu J, Cai Y, Li M, Zhang Y, Li H, Tan Z. Oxymatrine Promotes S-Phase Arrest and Inhibits Cell Proliferation of Human Breast Cancer Cells in Vitro through Mitochondria-Mediated Apoptosis. Biol Pharm Bull. 2017;40(8):1232–1239. doi:10.1248/bpb.b17-00010

87. Li L, Chen X, Liu CC, Lee LS, Man C, Cheng SH. Phytoestrogen Bakuchiol Exhibits In Vitro and In Vivo Anti-breast Cancer Effects by Inducing S Phase Arrest and Apoptosis. Front Pharmacol. 2016;7:128. doi:10.3389/fphar.2016.00128

88. Li WY, Chan SW, Guo DJ, Chung MK, Leung TY, Yu PH. Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines. J Ethnopharmacol. 2009;124(2):251–256. doi:10.1016/j.jep.2009.04.030

89. Lin Y, Shen Y, Wu C, et al. Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells. Front Pharmacol. 2019;10:1226. doi:10.3389/fphar.2019.01226

90. Wang SH, Wu CH, Tsai CC, et al. Effects of Luteolin on Human Breast Cancer Using Gene Expression Array: inferring Novel Genes. Curr Issues Mol Biol. 2022;44(5):2107–2121. doi:10.3390/cimb44050142

91. Shi Y, Wang M, Wang P, et al. Alisol A is potentially therapeutic in human breast cancer cells. Oncol Rep. 2020;44(3):1266–1274. doi:10.3892/or.2020.7654

92. Liao M, Wang C, Yang B, et al. Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis. Front Pharmacol. 2021;12:659297. doi:10.3389/fphar.2021.659297

93. Wang WD, Shang Y, Li Y, Chen SZ. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation. Acta Pharmacol Sin. 2019;40(9):1219–1227. doi:10.1038/s41401-019-0240-x

94. Ma J, Li J, Wang Y, et al. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling. Biomed Pharmacother. 2020;121:109617. doi:10.1016/j.biopha.2019.109617

95. Wu J, Luo D, Li S. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer. Breast Cancer. 2020;12:267–277. doi:10.2147/BCTT.S284076

96. Li D, Su Y. PD-1/PD-L1 and PI3K/AKT cross-dialogue with breast cancer metaimmune microenvironment. Chine J Gerontol. 2022;42:215–218.

97. Zhao X, Liu J, Ge S, et al. Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance. Front Pharmacol. 2019;10:624. doi:10.3389/fphar.2019.00624

98. Li D, Fan H, Dong J, et al. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions. Breast Cancer. 2021;13:725–742. doi:10.2147/BCTT.S339607

99. Li D, Su Y, Fan H. Effect of Xihuang Pill on microcirculation in DMBA combined estrogen and progesterone induced breast precancerous lesions rats. IOP Conf Ser. 2020;474(5):052053. doi:10.1088/1755-1315/474/5/052053

100. Feng M, Wang H, Zhu Z, et al. Sanhuang Decoction Controls Tumor Microenvironment by Ameliorating Chronic Stress in Breast Cancer: a Report of Ninety Cases. Front Oncol. 2021;11:677939. doi:10.3389/fonc.2021.677939

101. Zhou R, Chen H, Chen J, Chen X, Wen Y, Xu L. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. BMC Complement Altern Med. 2018;18(1):83. doi:10.1186/s12906-018-2148-2

102. Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128–134. doi:10.1038/nrc.2017.118

103. Deshmukh SK, Srivastava SK, Tyagi N, et al. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings. Carcinogenesis. 2017;38(8):757–765. doi:10.1093/carcin/bgx037

104. Li D, Liu X, Tian X, Liu F, Yao X, Dong J and Gao Y. (2023). PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs. PPAR Research, 2023 1–18. 10.1155/2023/4481354

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.